Cargando…
Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
BACKGROUND: Approximately 90% of patients with metastatic colorectal cancer fail therapy mainly due to resistance. Taking advantage of currently approved agents for treatment of disease conditions other than cancer for the identification of new adjuvant anticancer therapies is highly encouraged. Pra...
Autores principales: | Al-Keilani, Maha S, Alsmadi, Dua H, Darweesh, Ruba S, Alzoubi, Karem H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842772/ https://www.ncbi.nlm.nih.gov/pubmed/29551915 http://dx.doi.org/10.2147/CPAA.S153780 |
Ejemplares similares
-
The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro
por: Safaeian, Leila, et al.
Publicado: (2020) -
The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
por: Al-Keilani, Maha S, et al.
Publicado: (2018) -
Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation
por: Neitzel, Carina, et al.
Publicado: (2019) -
Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
por: Almaaytah, Ammar, et al.
Publicado: (2018) -
Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer
por: Wen, Wei, et al.
Publicado: (2017)